Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
SZSE
Closed
Sep 18, 2026
Day's Range
48.8052 wk Range
37.50Overview - 300832 - Shenzhen New Industries Biomedical Engineering Co., Ltd.
Key Statistics
Valuation
Enterprise Value
34.44B
P/E (Trailing)
‪22.12‬
P/E (Forward)
‪18.12‬
PEG Ratio
‪18.12‬
Price / Sales (TTM)
‪7.91‬
Price / Book
‪4.24‬
EV / EBITDA
‪16.12‬
Profitability
Gross Margin
‪68.61%‬
Profit Margin
‪35.67%‬
Operating Margin
‪36.97%‬
Return on Assets
‪12.98%‬
Return on Equity
‪19.87%‬
Ownership
Shares Outstanding
785.71M
Float
329.13M
Held by Insiders
‪48.54%‬
Held by Institutions
‪22.34%‬
Price stats
Beta
‪-0.29‬
50-Day Avg
‪48.12‬
200-Day Avg
‪50.45‬
Dividends
Payout Ratio
‪54.88%‬
Frequency
Annual
Analyst Consensus
11 analysts
Average price target
‪CN¥ 66.07‬Market Cap - 300832 - Shenzhen New Industries Biomedical Engineering Co., Ltd.
Peers - 300832 - Shenzhen New Industries Biomedical Engineering Co., Ltd.
Peer Comparison
Compared with companies in Medical Devices listed on SZSE.
Profile Summary - 300832 - Shenzhen New Industries Biomedical Engineering Co., Ltd.
About
Shenzhen New Industries Biomedical Engineering Co., Ltd., commonly referred to as Snibe, is a leading company in the biotechnology and healthcare industry. The company specializes in the research, development, manufacturing, and sales of in-vitro diagnostic devices, playing a crucial role in advancing medical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
